CF vs FDMT · P/E 12, rev $5.94B vs rev $37.0K
CF Industries Holdings Inc (CF) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
CF currently screens at market cap $14.98B and trailing P/E 12.2. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the CF and FDMT stock pages for the full models.
Not investment advice.